Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Girard

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Scientific Reports|January 15, 2022
Cortical morphology predicts placebo response in multiple sclerosisMariya V Cherkasova, Jessie F Fu, Michael Jarrett, et al.
Therapeutic Advances in Neurological Disorders|February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapiesHelmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 14, 2022
CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple SclerosisAntoine Philippe Fournier, Stephanie Zandee, Marc Charabati, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Gaining Biological Insights through Supervised Data VisualizationJake S Rhodes, Adrien Aumon, Sacha Morin, et al.
Nature Computational Science|June 30, 2026
Gaining biological insights through supervised data visualizationJake S Rhodes, Adrien Aumon, Sacha Morin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 3, 2025
Peripheral HLA-DR<sup>hi</sup>CD141<sup>+</sup> Classical Monocytes Predict Relapse Risk and Worsening in Multiple SclerosisKarine Thai, Rose-Marie Rebillard, Wendy Klement, et al.
Vaccine|May 27, 2008
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumPierre-Alexandre Bart, Ruth Goodall, Tristan Barber, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2018
Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosisMyintzu Min, Tim Spelman, Alessandra Lugaresi, et al.
Multiple Sclerosis and Related Disorders|June 15, 2023
Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated diseaseHayet Boudjani, Giulia Fadda, Gabrielle Dufort, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Scientific Reports|January 15, 2022
Cortical morphology predicts placebo response in multiple sclerosisMariya V Cherkasova, Jessie F Fu, Michael Jarrett, et al.
Therapeutic Advances in Neurological Disorders|February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapiesHelmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 14, 2022
CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple SclerosisAntoine Philippe Fournier, Stephanie Zandee, Marc Charabati, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Gaining Biological Insights through Supervised Data VisualizationJake S Rhodes, Adrien Aumon, Sacha Morin, et al.
Nature Computational Science|June 30, 2026
Gaining biological insights through supervised data visualizationJake S Rhodes, Adrien Aumon, Sacha Morin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 3, 2025
Peripheral HLA-DR<sup>hi</sup>CD141<sup>+</sup> Classical Monocytes Predict Relapse Risk and Worsening in Multiple SclerosisKarine Thai, Rose-Marie Rebillard, Wendy Klement, et al.
Vaccine|May 27, 2008
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumPierre-Alexandre Bart, Ruth Goodall, Tristan Barber, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2018
Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosisMyintzu Min, Tim Spelman, Alessandra Lugaresi, et al.
Multiple Sclerosis and Related Disorders|June 15, 2023
Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated diseaseHayet Boudjani, Giulia Fadda, Gabrielle Dufort, et al.
Pageof 12